Filing Details

Accession Number:
0001209191-22-057368
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-16 17:53:51
Reporting Period:
2022-11-14
Accepted Time:
2022-11-16 17:53:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831915 Cytek Biosciences Inc. CTKB Laboratory Analytical Instruments (3826) 472547526
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1873083 Jack Ball C/O Cytek Biosciences, Inc.
46107 Landing Parkway
Fremont CA 94538
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-14 16,000 $0.40 19,000 No 4 M Direct
Common Stock Disposition 2022-11-14 16,000 $14.69 3,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-11-14 16,000 $0.00 16,000 $0.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,666 2020-10-12 2028-10-12 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.53 to $14.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.